ID
26633
Description
A Study of Avastin (Bevacizumab) in Combination With Neoadjuvant Treatment Regimens in Patients With Primary HER2 Negative Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00773695
Link
https://clinicaltrials.gov/show/NCT00773695
Keywords
Versions (2)
- 10/19/17 10/19/17 -
- 10/22/17 10/22/17 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
October 22, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00773695
Eligibility Breast Cancer NCT00773695
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Neoplasm Metastasis
Data type
boolean
Alias
- UMLS CUI [1]
- C0027627
Description
Therapeutic procedure Breast Carcinoma Localized
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0678222
- UMLS CUI [1,3]
- C0392752
Description
Cancer Other | Exception Basal cell carcinoma | Exception Carcinoma in situ of uterine cervix
Data type
boolean
Alias
- UMLS CUI [1]
- C1707251
- UMLS CUI [2,1]
- C1705847
- UMLS CUI [2,2]
- C0007117
- UMLS CUI [3,1]
- C1705847
- UMLS CUI [3,2]
- C0851140
Description
Aspirin U/day
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0004057
- UMLS CUI [1,2]
- C0456683
Description
Cardiovascular Disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0007222
Similar models
Eligibility Breast Cancer NCT00773695
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C4087376 (UMLS CUI [1,2])
C0456389 (UMLS CUI [1,3])
C1298650 (UMLS CUI [2])
C0428772 (UMLS CUI [2])
C0678222 (UMLS CUI [1,2])
C0392752 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C0456683 (UMLS CUI [1,2])